These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6152347)

  • 21. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics.
    Wirtshafter D
    Eur J Pharmacol; 1998 Oct; 358(3):R1-3. PubMed ID: 9822897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoalkylindoles: atypical dopamine antagonists.
    Costall B; Dannenburg WN; Johnson DN; Naylor RJ
    J Pharm Pharmacol; 1983 Apr; 35(4):229-33. PubMed ID: 6133932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of neuroleptics on acetylcholine concentration and choline uptake in striatum: Implications for regulation of acetylcholine metabolism.
    Sherman KA; Hanin I; Zigmond MJ
    J Pharmacol Exp Ther; 1978 Sep; 206(3):677-86. PubMed ID: 29960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
    Lai H; Carino MA; Horita A
    Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
    Terai M; Hidaka K; Nakamura Y
    Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism.
    Brougham LR; Conway PG; Ellis DB
    Neuropharmacology; 1991 Oct; 30(10):1137-40. PubMed ID: 1684649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of neuroleptics on dopamine release from striatal slices.
    Yamada S; Kojima H; Tsutsumi T; Yokoo H; Takamuki K; Anraku S; Nishi S; Inanaga K
    Kurume Med J; 1985; 32(2):127-30. PubMed ID: 3831593
    [No Abstract]   [Full Text] [Related]  

  • 31. Regional selectivity of neuroleptic drugs: an argument for site specificity.
    Borison RL; Diamond BI
    Brain Res Bull; 1983 Aug; 11(2):215-8. PubMed ID: 6138135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
    Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
    Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H; Sudo K; Sano M
    Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
    Tissari AH
    Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increases in rat striatal preproenkephalin mRNA levels following chronic treatment with the depot neuroleptic, haloperidol decanoate.
    Petrack B; Emmett MR; Rao TS; Kim HS; Wood PL
    Life Sci; 1990; 46(10):687-91. PubMed ID: 1969106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 59(3):211-6. PubMed ID: 32570
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia.
    Parsons B; Togasaki DM; Kassir S; Przedborski S
    J Neurochem; 1995 Nov; 65(5):2057-64. PubMed ID: 7595490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.